|
|
|
|
PRF281
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases/28 cores
|
|
| Microarray Panel: | Prostate carcinoma tissue microarray, including 24 cases of prostate adenocarcinoma and 4 cases of normal prostate tissue, single core per case (cold acetone fixed) |
| Cores: | 28 |
|
| Cases: | 28 |
| Layout: | 7 cols × 4 rows |
| Core Diameter: | 2 mm |
| Thickness: | 5 µm | | Quality Control: | H&E and Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Tissues were snap frozen in liquid nitrogen immediately after excision and were embedded in OCT. The array sections are 5-8 µm in thickness, mounted on positively charged glass slides, and briefly fixed by cold acetone. |
*Tissue Microarray Slide Types:
- Unstained: unstained
frozen
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Pro - Prostate
 - Malignant tumor,
 - Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Gleason Score |
Type † |
|
A1 |
1 |
M |
66 |
Prostate |
Normal |
– |
– |
Normal |
|
A2 |
2 |
M |
69 |
Prostate |
Normal |
– |
– |
Normal |
|
A3 |
3 |
M |
50 |
Prostate |
Normal |
– |
– |
Normal |
|
A4 |
4 |
M |
44 |
Prostate |
Normal |
– |
– |
Normal |
|
A5 |
5 |
M |
51 |
Prostate |
Adenocarcinoma |
III |
3+4=7 |
Malignant |
|
A6 |
6 |
M |
81 |
Prostate |
Adenocarcinoma |
II |
3+3=6 |
Malignant |
|
A7 |
7 |
M |
62 |
Prostate |
Adenocarcinoma |
III |
3+4=7 |
Malignant |
|
B1 |
8 |
M |
76 |
Prostate |
Adenocarcinoma |
I |
2+2=4 |
Malignant |
|
B2 |
9 |
M |
75 |
Prostate |
Adenocarcinoma |
IV |
4+5=9 |
Malignant |
|
B3 |
10 |
M |
43 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
B4 |
11 |
M |
78 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
B5 |
12 |
M |
71 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
B6 |
13 |
M |
80 |
Prostate |
Adenocarcinoma |
II |
3+3=6 |
Malignant |
|
B7 |
14 |
M |
66 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
C1 |
15 |
M |
83 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
C2 |
16 |
M |
76 |
Prostate |
Adenocarcinoma |
II |
3+3=6 |
Malignant |
|
C3 |
17 |
M |
63 |
Prostate |
Adenocarcinoma |
III |
5+3=8 |
Malignant |
|
C4 |
18 |
M |
66 |
Prostate |
Adenocarcinoma |
III |
3+4=7 |
Malignant |
|
C5 |
19 |
M |
87 |
Prostate |
Adenocarcinoma |
III |
3+4=7 |
Malignant |
|
C6 |
20 |
M |
71 |
Prostate |
Adenocarcinoma |
III |
4+4=8 |
Malignant |
|
C7 |
21 |
M |
65 |
Prostate |
Adenocarcinoma |
IV |
5+4=9 |
Malignant |
|
D1 |
22 |
M |
77 |
Prostate |
Adenocarcinoma |
III |
4+3=7 |
Malignant |
|
D2 |
23 |
M |
79 |
Prostate |
Adenocarcinoma |
II |
2+3=5 |
Malignant |
|
D3 |
24 |
M |
77 |
Prostate |
Adenocarcinoma |
III |
5+3=8 |
Malignant |
|
D4 |
25 |
M |
61 |
Prostate |
Adenocarcinoma |
II |
3+2=5 |
Malignant |
|
D5 |
26 |
M |
77 |
Prostate |
Adenocarcinoma |
III |
4+4=8 |
Malignant |
|
D6 |
27 |
M |
69 |
Prostate |
Adenocarcinoma |
I |
2+2=4 |
Malignant |
|
D7 |
28 |
M |
95 |
Prostate |
Adenocarcinoma |
III |
5+3=8 |
Malignant |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
Sorry, this tissue array cannot be compared to find overlapping cases.
|
